Imatinib 100mg is used in the treatment of certain types of cancers, such as chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs).
Additional Information
Side Effects
as configured:
Prescription Required
as configured:
Composition
Imatinib
as configured:
Comorbid Conditions
as configured:
Disease Coding \(ICD-10\)
as configured:
Therapeutic Indication
as configured:
Disease Biomarker
as configured:
Patient Population
as configured:
Disease Stage
as configured:
Disease Subtype
as configured:
Disease Name
as configured:
Disease Category
as configured:
Therapeutic Area
as configured:
Storage Class
as configured:
Clinical Trial Reference
as configured:
Approval Date
as configured:
Patient Leaflet \(PIL\) Link
as configured:
Pharmacological Class
as configured:
Pharmaceutical Category
as configured:
Additional Market and Clinical Insights
as configured:
All Brands Available \(Kenya & Globaly\)
as configured:
Local Regulatory Status
as configured:
Insurance Formulary Tags
as configured:
1st line, 2nd line, 3rd Line \(WHO, SHA, Private Insurance\)
as configured:
Hospital Level Tagging \(EML\)
as configured:
Dosage & Administration
as configured:
Most Demanded Strength & Formulation
as configured:
Most Prescribed in Class
as configured:
Indications
as configured:
Mechanism of Action
as configured:
Directions for Use
as configured:
Related Products
Reviews
Only registered users can write reviews. Please, log in or register